Erika Sloan

She has expertise in market research, opportunity assessment, competitive intelligence, and strategy projects across a broad variety of therapeutic areas, both globally and in the US. Her main fields of expertise are in neuroscience, rare disease, and oncology. Prior to CRA’s acquisition in 2017, Ms. Sloan was a manager at C1 Consulting and helped start its first ex-US office in Lucerne, Switzerland.